South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.

South Africa's competition watchdog launches a crucial investigation into pharmaceutical giants Novo Nordisk and Sanofi over ...

After a decade of being the primary supplier of human insulin pens in South Africa, Novo decided against bidding for the 2024 ...

Callio Therapeutics has raised $187m in a Series A financing round to achieve clinical proof-of-concept for its human ...

Biotech-focused investment firm Frazier Life Sciences launched Callio Therapeutics, a cancer treatment startup with ...

Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from Singapore-based Hummingbird BioscienceFinancing ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The FBI told managers that 1,500 personnel will be transferred from the headquarters near Washington headquarters to offices around the country, including around a third being placed in an Alabama ...

The FDA today declared the national deficit of GLP-1 diet drugs at an end. Well, at least for Novo Nordisk's Ozempic and Wegovy. Novo Nordisk sales should be going up, and Hims & Hers Health's ...

Florida Gov. Ron DeSantis would like to see NASA move its headquarters to Brevard County, the rocket launch capital of the world. "There is an interest in moving the headquarters of NASA right ...

However, in June 2024 Novo Nordisk said it was recognising a loss of around 5.7 billion Danish crowns (US$800 million) in relation to the drug after adverse clinical trial results.